MDL-001

N/A

Report date: 2023/02/26 21:49:44
NME

Base Information

Drug NameMDL-001
Drug Alias NameMDL001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesModel Medicines
China Registration ClassN/A

Develop Information

Active CompaniesModel Medicines
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A